304 related articles for article (PubMed ID: 32900822)
1. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.
Brocato RL; Principe LM; Kim RK; Zeng X; Williams JA; Liu Y; Li R; Smith JM; Golden JW; Gangemi D; Youssef S; Wang Z; Glanville J; Hooper JW
J Virol; 2020 Oct; 94(22):. PubMed ID: 32900822
[TBL] [Abstract][Full Text] [Related]
2. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.
Sia SF; Yan LM; Chin AWH; Fung K; Choy KT; Wong AYL; Kaewpreedee P; Perera RAPM; Poon LLM; Nicholls JM; Peiris M; Yen HL
Nature; 2020 Jul; 583(7818):834-838. PubMed ID: 32408338
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
[TBL] [Abstract][Full Text] [Related]
6. Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters.
Osterrieder N; Bertzbach LD; Dietert K; Abdelgawad A; Vladimirova D; Kunec D; Hoffmann D; Beer M; Gruber AD; Trimpert J
Viruses; 2020 Jul; 12(7):. PubMed ID: 32698441
[TBL] [Abstract][Full Text] [Related]
7. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.
Boudewijns R; Thibaut HJ; Kaptein SJF; Li R; Vergote V; Seldeslachts L; Van Weyenbergh J; De Keyzer C; Bervoets L; Sharma S; Liesenborghs L; Ma J; Jansen S; Van Looveren D; Vercruysse T; Wang X; Jochmans D; Martens E; Roose K; De Vlieger D; Schepens B; Van Buyten T; Jacobs S; Liu Y; Martí-Carreras J; Vanmechelen B; Wawina-Bokalanga T; Delang L; Rocha-Pereira J; Coelmont L; Chiu W; Leyssen P; Heylen E; Schols D; Wang L; Close L; Matthijnssens J; Van Ranst M; Compernolle V; Schramm G; Van Laere K; Saelens X; Callewaert N; Opdenakker G; Maes P; Weynand B; Cawthorne C; Vande Velde G; Wang Z; Neyts J; Dallmeier K
Nat Commun; 2020 Nov; 11(1):5838. PubMed ID: 33203860
[TBL] [Abstract][Full Text] [Related]
8. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2.
Braxton AM; Creisher PS; Ruiz-Bedoya CA; Mulka KR; Dhakal S; Ordonez AA; Beck SE; Jain SK; Villano JS
Comp Med; 2021 Oct; 71(5):398-410. PubMed ID: 34588095
[TBL] [Abstract][Full Text] [Related]
9. [Clinical symptoms and signs in hamsters during experimental infection with the SARS-CoV-2 virus (Coronaviridae:
Tuyskanova MS; Zhugunissov KD; Ozaslan M; Myrzakhmetova BS; Kutumbetov LB
Vopr Virusol; 2023 Dec; 68(6):513-525. PubMed ID: 38156567
[TBL] [Abstract][Full Text] [Related]
10. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H
J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068
[TBL] [Abstract][Full Text] [Related]
11. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
[TBL] [Abstract][Full Text] [Related]
12. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling.
Bednash JS; Kagan VE; Englert JA; Farkas D; Tyurina YY; Tyurin VA; Samovich SN; Farkas L; Elhance A; Johns F; Lee H; Cheng L; Majumdar A; Jones D; Mejia OR; Ruane-Foster M; Londino JD; Mallampalli RK; Robinson RT
Transl Res; 2022 Feb; 240():1-16. PubMed ID: 34740873
[TBL] [Abstract][Full Text] [Related]
13. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
Corbett KS; Flynn B; Foulds KE; Francica JR; Boyoglu-Barnum S; Werner AP; Flach B; O'Connell S; Bock KW; Minai M; Nagata BM; Andersen H; Martinez DR; Noe AT; Douek N; Donaldson MM; Nji NN; Alvarado GS; Edwards DK; Flebbe DR; Lamb E; Doria-Rose NA; Lin BC; Louder MK; O'Dell S; Schmidt SD; Phung E; Chang LA; Yap C; Todd JM; Pessaint L; Van Ry A; Browne S; Greenhouse J; Putman-Taylor T; Strasbaugh A; Campbell TA; Cook A; Dodson A; Steingrebe K; Shi W; Zhang Y; Abiona OM; Wang L; Pegu A; Yang ES; Leung K; Zhou T; Teng IT; Widge A; Gordon I; Novik L; Gillespie RA; Loomis RJ; Moliva JI; Stewart-Jones G; Himansu S; Kong WP; Nason MC; Morabito KM; Ruckwardt TJ; Ledgerwood JE; Gaudinski MR; Kwong PD; Mascola JR; Carfi A; Lewis MG; Baric RS; McDermott A; Moore IN; Sullivan NJ; Roederer M; Seder RA; Graham BS
N Engl J Med; 2020 Oct; 383(16):1544-1555. PubMed ID: 32722908
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
[TBL] [Abstract][Full Text] [Related]
16. J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases.
Lee H; Lee TY; Jeon P; Kim N; Kim JW; Yang JS; Kim KC; Lee JY
J Virol Methods; 2022 Jan; 299():114306. PubMed ID: 34601000
[TBL] [Abstract][Full Text] [Related]
17. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters.
Cong Y; Mucker EM; Perry DL; Dixit S; Kollins E; Byrum R; Huzella L; Kim R; Josleyn M; Kwilas S; Stefan C; Shoemaker CJ; Koehler J; Coyne S; Delp K; Liang J; Drawbaugh D; Hischak A; Hart R; Postnikova E; Vaughan N; Asher J; St Claire M; Hanson J; Schmaljohn C; Eakin AE; Hooper JW; Holbrook MR
Antiviral Res; 2023 May; 213():105589. PubMed ID: 37003305
[TBL] [Abstract][Full Text] [Related]
20. Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model.
Patel DR; Minns AM; Sim DG; Field CJ; Kerr AE; Heinly TA; Luley EH; Rossi RM; Bator CM; Moustafa IM; Norton EB; Hafenstein SL; Lindner SE; Sutton TC
Microbiol Spectr; 2024 Mar; 12(3):e0499822. PubMed ID: 38334387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
